Sequence of full-length RNA (Ribonucleic Acid) molecule based on nanopore, targeted direct sequencing method for epigenetic modification and application of targeted direct sequencing method

By using extended linkers to extend the RNA ends in nanopore sequencing technology, the problem of large errors in full-length RNA sequencing in nanopore direct sequencing technology is solved, and high accuracy and high throughput RNA sequencing are achieved, which is suitable for a variety of applications.

CN120082638APending Publication Date: 2025-06-03RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202510249564.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-03-04
Publication Date
2025-06-03

AI Technical Summary

Technical Problem

The existing nanopore direct sequencing technology has extremely high sequencing errors at the 5’ and 3’ ends of RNA, and it is impossible to achieve direct sequencing of full-length RNA.

Method used

The 5’ and 3’ ends of the RNA molecule are extended by ligating the extension linker, including DNA probes, 5’ extension RNA (ER5) and 3’ extension RNA (ER3), to compensate for the high sequencing errors at the ends and achieve direct sequencing of full-length RNA.

Benefits of technology

Highly accurate sequencing of full-length RNA is achieved, sequencing bias is reduced, and the abundance, sequence and epigenetic modification information of RNA can be obtained simultaneously. It is suitable for a variety of nanopore platforms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120082638A_ABST
    Figure CN120082638A_ABST
Patent Text Reader

Abstract

The invention discloses a target direct sequencing method based on the sequence and epigenetic modification of a full-length RNA (Ribonucleic Acid) molecule of a nanopore, and belongs to the technical field of RNA sequencing. Aiming at the problem that a nanopore cannot directly perform targeted sequencing on RNA, an extension joint is designed to prolong 5'and 3 'ends of an RNA molecule and compensate high sequencing errors of the tail ends, so that a middle RNA sequence is completely sequenced; the extension linker comprises a DNA probe, 5'extension RNA (ER5) and 3 'extension RNA (ER3), the DNA probe can specifically capture RNA molecules and enhance connection with the extension RNA, self-connection of RNA or the extension RNA is reduced to a great extent so as to ensure efficient and accurate RNA extension, target RNA is captured based on sequence complementation, connection deviation caused by different sequences is reduced, and the detection sensitivity is improved. And target sequencing can be carried out on interested RNA types. By constructing a targeted direct sequencing method of specific RNA based on nanopores, the problems that RNA cannot be detected and cannot be accurately detected in direct sequencing based on nanopores are solved, high-throughput and high-precision RNA sequencing is realized, full-length RNA direct sequencing is realized, information such as RNA abundance, sequence, epigenetic modification and the like is obtained at the same time through single sequencing, and the method is suitable for large-scale popularization and application. And a cancer diagnosis model can be constructed in combination with methods such as machine learning and the like, so that high-accuracy and high-specificity diagnosis of cancers is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of RNA sequencing, and in particular to a method for targeted direct sequencing of the sequence and epigenetic modification of full-length RNA molecules based on nanopores and its applications. Background Art

[0002] The information disclosed in the background art of the present invention is only intended to increase the understanding of the overall background of the present invention, and does not necessarily constitute an admission or imply in any form that this information is prior art that is already known to those of ordinary skill in the art.

[0003] With the development of molecular biotechnology, modern biological and biomedical research has entered the "omics" research stage, that is, by capturing tens of millions of molecular dynamic information in cells to study the global metabolic network and operating mechanism in cells, such as functional genomics, proteomics, metabolomics, etc. Among them, as the carrier of genetic information, many other functions of RNA molecules in cells have gradually been revealed, such as regulating gene expression, biocatalysis, regulating protein translation efficiency, cell drug resistance, etc.

[0004] Next-Generation Sequencing (NGS), also known as high-throughput sequencing, that is, quantitatively obtaining the sequence and abundance information of RNA through high-throughput sequencing, has become the main means in the current RNA research field. The library construction methods for NGS to sequence RNA mainly include steps such as 5', 3' adapter ligation, reverse transcription, PCR amplification, etc. At the same time, combined with antibody capture of methylation sequences, methylation sequence information can be obtained. However, due to sequence biases during library construction, such as blunt-end ligation of sequencing adapters and PCR amplification, NGS has a high sequencing bias among different RNA sequences, and thus lacks quantitative accuracy. In addition, NGS cannot directly detect the epigenetic modification of RNA, and it must be combined with antibody-based methylation RNA enrichment. This method not only requires a large amount of methylated modified RNA, but also has a low accuracy in identifying methylated RNA due to non-specific capture of methylation antibodies.

[0005] Nanopore-based direct RNA sequencing (DRS) can simultaneously detect the abundance, sequence, and modification information of RNA. Because of the single-molecule and single-base resolution of nanopore sequencing and the absence of amplification, it can provide highly accurate RNA quantitative information. However, due to the extremely high sequencing errors at the 5' and 3' ends of RNA in existing nanopore direct sequencing technologies, and the loss of approximately 15 nt of sequence at the 5' end, the full-length direct sequencing of RNA has not yet been achieved.

[0006] Chinese Patent CN 109295187 A discloses a nanopore-induced phase shift sequencing method that achieves direct RNA sequencing on a customized nanopore platform. However, this method can only detect the sequence and modification information of RNAs up to 15 nt in length and cannot sequence full-length RNAs. In addition, this method is incompatible with nanopore sequencing such as the Oxford Nanopore Technology platform (ONT) and cannot achieve accessible, mature, and high-throughput RNA sequencing.

[0007] Therefore, it is necessary to develop a nanopore-based targeted direct sequencing method for the sequence and epigenetic modification of full-length RNA molecules to solve the above problems. Summary of the Invention

[0008] Aiming at the deficiencies in the prior art, the purpose of the present invention is to provide a nanopore-based targeted direct sequencing method for the sequence and epigenetic modification of full-length RNA molecules to address problems such as the inability of nanopores to directly target and sequence RNAs.

[0009] To achieve the above objective, the present invention adopts the following technical solutions:

[0010] A nanopore-based targeted direct sequencing method for the sequence and epigenetic modification of full-length RNA molecules, which extends the 5' and 3' ends of the RNA molecule to be tested by ligating extension adapters and then performs nanopore sequencing on the extended RNA molecule.

[0011] Further, the extension adapter consists of three parts: a DNA probe, 5' extended RNA (5ER), and 3' extended RNA (3ER), and the 3' extended RNA contains a poly-A tail for sequencing adapter ligation.

[0012] Further, the method is applicable to various nanopore sequencing platforms, including but not limited to nanopore sequencing chips such as the Oxford Nanopore sequencing platform and the Qitan Technology nanopore sequencing platform.

[0013] The present invention also provides an application of the above-mentioned nanopore-based targeted direct sequencing method for the sequence and epigenetic modification of full-length RNA molecules. The method is applied to direct sequencing of full-length RNAs, biological mechanism research, or clinical research (such as disease diagnosis, prognosis monitoring, etc.), for example, constructing a cancer diagnosis model by combining methods such as machine learning.

[0014] The beneficial effects of the present invention are as follows:

[0015] In view of the problem that nanopores cannot directly target and sequence RNA, the present invention designs extension adapters to extend the 5' and 3' ends of RNA molecules, compensating for the high sequencing error at the ends, so that the middle RNA sequence can be completely sequenced; the extension adapter includes a DNA probe, 5' extended RNA (ER5) and 3' extended RNA (ER3). The DNA probe can specifically capture RNA molecules and enhance the ligation with the extended RNA, greatly reducing the self-ligation of RNA or extended RNA to ensure efficient and accurate RNA extension. It also captures the targeted RNA based on sequence complementarity, which not only reduces the ligation bias caused by different sequences, but also enables targeted sequencing of the RNA species of interest. By constructing a specific RNA targeted direct sequencing method based on nanopores, the present invention solves the problems such as RNA being unable to be sequenced or inaccurately sequenced in direct nanopore sequencing, realizes high-throughput and high-precision RNA sequencing, realizes direct full-length RNA sequencing, and simultaneously obtains information such as the abundance, sequence, and epigenetic modification of RNA in a single sequencing. It can be applied to a variety of nanopore platforms and can also be applied to biological mechanism research or clinical research such as disease diagnosis and prognosis monitoring.

[0016] The above description is only an overview of the technical solution of the present invention. In order to be able to understand the technical means of the present invention more clearly and implement it in accordance with the content of the description, the following will describe in detail with reference to the preferred embodiments of the present invention and the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] In order to more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the following will briefly introduce the drawings required for the description of the specific embodiments or the prior art. Obviously, some of the drawings in the following description are embodiments of the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without creative efforts.

[0018] Figure 1 : a, Traditional direct RNA sequencing library construction method. b, Library construction method for targeted capture of RNA. c, IGV graph showing the feasibility of Targeted-RNA-seq, including high coverage and low error rate. d, The values and ratios of the reads measured by DRS and Targeted-RNA-seq and the reads aligned with the reference sequence. e, Reproducibility of Targeted-RNA-seq demonstrated using RNA extracted from cells.

[0019] Figure 2: a, The ratios of the actual reads to the expected reads of the three sequencing methods are used to show the quantification accuracy of the three methods. b, The coefficient of variation is used to quantitatively analyze the quantification accuracy of the three methods for the data from a. c, The quantification performance of Targeted-RNA-seq is evaluated using RNAs at different concentrations. d, The ability of Targeted-RNA-seq to distinguish single-base mutations and double-base mutations is evaluated. Detailed implementation manners

[0020] To better describe the present invention, the following further illustrates through specific embodiments. The methods in the following embodiments are all conventional methods unless otherwise specified.

[0021] The technical solutions of the present invention are all conventional solutions in the art unless otherwise specified; the reagents or materials are all from commercial channels unless otherwise specified.

[0022] The following detailed descriptions are all illustrative and are intended to provide further descriptions of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as commonly understood by those of ordinary skill in the technical field to which the present application belongs. The following examples are only for explaining the present invention and do not limit its content. If the specific experimental conditions are not indicated in the examples, they are usually in accordance with conventional conditions or the conditions recommended by reagent companies; the reagents, consumables, etc. used in the following embodiments can be obtained from commercial channels unless otherwise specified.

[0023] The present invention provides a targeted direct sequencing method, Targeted-RNA-seq, for the sequence and epigenetic modification of full-length RNA molecules based on nanopores. The process and principle of this method are as follows:

[0024] Please refer to Figure 1 , for the problem that nanopores cannot directly target the sequencing of RNA ( Figure 1 a), the present invention extends the 5' and 3' ends of the RNA molecule by ligating an extension adapter, which can compensate for the high sequencing error at the ends, so that the middle RNA sequence can be completely sequenced. Figure 1b). The extension adapter consists of three parts: a DNA probe, 5' extended RNA (ER5), and 3' extended RNA (ER3, containing a poly-A tail for sequencing adapter ligation). Introducing the DNA probe brings the following benefits: (1) Considering the low ligation efficiency of free single-stranded RNA, the DNA probe can specifically capture RNA molecules and enhance the ligation with extended RNA. (2) The presence of the DNA probe can largely reduce the self-ligation of RNA or extended RNA to ensure efficient and accurate RNA extension. (3) The DNA probe captures the target RNA based on sequence complementarity, which not only reduces the ligation bias caused by different sequences but also enables targeted sequencing of the RNA species of interest.

[0025] The present application will be further described below with specific embodiments:

[0026] Example 1 Library construction for Targeted-RNA-seq:

[0027] The library construction method for direct RNA targeting sequencing based on the Oxford Nanopore sequencing platform is as follows:

[0028] In the first annealing step, ER5, ER3, RNA, and the DNA probe are mixed in 1×T4 DNA ligase buffer to bring the total volume of all RNAs to 20 μL. For synthetic RNA sequencing, the molar ratio of ER5, ER3, the DNA probe, and RNA is 2:2:2:1. For cellular RNA sequencing and serum RNA sequencing, the molar ratio of ER5, ER3, the DNA probe, and RNA is 4:4:4:1. For cellular RNA sequencing, from 2.5×10 6RNA was extracted from each cell, and 3 fmol of ER5, 3 fmol of ER3, and 3 fmol of DNA probe were added to each RNA species. For serum RNA sequencing, 4 mL of RNA was extracted from the serum of gastric cancer patients or non-gastric cancer controls, and 30 amol of ER5, 30 amol of ER3, and 30 amol of DNA probe were added to each RNA. Then they were denatured at 70 °C for 5 minutes and annealed gradiently to 4 °C and kept for 15 minutes. After that, 1 μL of RTA (SQK-RNA002), 6 μL of RMX (SQK-RNA002), 5 μL of T4 DNA ligase, 2 μL of 10 mM ATP, 3 μL of 10×T4 DNA ligase buffer, 7 μL of 50% PEG6000, and 6 μL of depc-treated water were added and incubated at room temperature for 10 minutes. 100 μL of AgencourtRNACleanXP magnetic beads were added to the above solution and incubated without interference at room temperature for 5 minutes. Then the supernatant was magnetically separated and removed. It was washed twice with 200 μL of WSB (SQK-RNA002). After washing, the magnetic beads were resuspended in 21 μL of ELB (SQK-RNA002) and incubated at room temperature for 10 min. The eluate was magnetically separated and prepared for loading onto the sequencing chip.

[0029] The library construction method for the above direct RNA targeted sequencing has the characteristics of high coverage, good repeatability, and high data output. In other embodiments, direct RNA targeted sequencing and library construction can also be performed through sequencing platforms such as the odd-carbon technology nanopore sequencing platform, which also has the characteristics of high coverage, good repeatability, and high data output.

[0030] Example 2 Comparison between Targeted-RNA-seq and existing sequencing methods:

[0031] Targeted-RNA-seq sequencing was performed on 12 synthetic RNAs. Compared with standard RNA direct sequencing (DRS), Targeted-RNA-seq achieved high-data-volume, high-coverage, and high-accuracy RNA direct sequencing ( Figure 1 c, d). Through the sequencing of cellular RNA, it was verified that even in a complex RNA environment, Targeted-RNA-seq can still achieve high-precision RNA direct sequencing with a simple and efficient library construction method. At the same time, through the biological replication sequencing of cellular RNA, it was proved that Targeted-RNA-seq has good repeatability ( Figure 1 e).

[0032] The sequencing counts of 12 synthetic RNAs with the same input amount were further analyzed to evaluate the quantitative bias between different RNAs by Targeted-RNA-seq. The read ratio of each RNA was calculated by dividing the expected sequencing count (total count divided by 12) by the observed sequencing count ( Figure 2 a). The results showed that for Targeted-RNA-seq, the abundances of 11 out of 12 RNAs were within 2-fold of the expected value, and only the count of Let-7a-5p was slightly greater than 2-fold. In contrast, DRS and Illumina-based small RNA sequencing (NGS) showed higher differences between RNA species, with DRS having the highest quantitative bias ( Figure 2 b). The powerful quantitative ability of Targeted-RNA-seq is due to the introduction of DNA probes to minimize the variation caused by ligation bias.

[0033] Nanopore-based direct RNA targeting sequencing can quantitatively and specifically detect RNA. Compared with standard direct RNA sequencing and second-generation small RNA sequencing, Targeted-RNA-seq has lower library construction bias.

[0034] To evaluate the accuracy of its quantitative RNA, synthetic miR-21-5p and miR-16-5p at different concentrations were sequenced and distinguished by 15-nt barcodes on ER3. The results showed that Targeted-RNA-seq provided an accurate estimate of RNA abundance (miR-21-5p R 2 = 0.92; miR-16-5p R 2 = 0.93), showing excellent quantitative ability for RNAs with different input amounts ( Figure 2 c). To study the detection specificity of Targeted-RNA-seq, the DNA probe of Let-7a was used to distinguish Let-7a from other family members with single-nucleotide or dinucleotide variations, including Let-7b, Let-7d, Let-7e, and Let-7f. The results showed that the vast majority of reads matched Let-7a, indicating that Targeted-RNA-seq successfully distinguished Let-7a from other family members ( Figure 2 d).

[0035] The nanopore sequencing data processing method in the above sequencing process is as follows:

[0036] Base recognition was performed by Guppy (v6.5.7) in high-accuracy mode (hac). All uracils were converted to thymines before alignment to simplify the downstream analysis process. Sequences shorter than 48 nt were removed. The remaining sequences were aligned to the reference sequence using BWA MEM (v0.7.17-r1188) with the alignment parameters of "-x ont2d, -k 10, -T 20" to ensure high RNA coverage. In addition, for cellular RNA sequencing, the screened sequences were first aligned to the target RNA. Then the unaligned sequences were aligned to the following RNA databases: (1) the rRNA database from the National Center for Biotechnology Information Nucleotide; (2) the tRNA database composed of GtRNAdb and mitotRNAdb; (3) the miRNA database from miRbase; (4) the piRNA database from piRNAdb (https: / / www.pirnadb.org); (5) mature mRNAs, snRNAs, snoRNAs, lncRNAs and other non-coding RNAs from Ensembl and Rfam. The CCA sequence was supplemented at the 3' end of all tRNAs in GtRNAdb and mitotRNAdb, and then alignment was performed.

[0037] In summary, in view of the problem that nanopores cannot directly target and sequence RNA, the present invention designs an extension adapter to extend the 5' and 3' ends of RNA molecules, compensating for the high sequencing error at the ends, so that the middle RNA sequence can be completely sequenced; the extension adapter includes a DNA probe, 5' extended RNA (ER5) and 3' extended RNA (ER3). The DNA probe can specifically capture RNA molecules and enhance the ligation with the extended RNA, greatly reducing the self-ligation of RNA or extended RNA to ensure efficient and accurate RNA extension. It also captures the target RNA based on sequence complementarity, which not only reduces the ligation bias caused by different sequences, but also enables targeted sequencing of the RNA species of interest. By constructing a nanopore-based targeted direct sequencing method for specific RNA, the present invention solves the problems of RNA not being detectable or inaccurately sequenced in nanopore direct sequencing, realizes high-throughput and high-accuracy RNA sequencing, realizes full-length RNA direct sequencing, and simultaneously obtains multi-dimensional information such as RNA abundance, sequence, and epigenetic modification in a single sequencing. It can be applied to a variety of nanopore platforms and can also be applied to biological mechanism research or clinical research such as disease diagnosis and prognosis monitoring. For example, a cancer diagnosis model can be constructed by combining methods such as machine learning to achieve high-accuracy and high-specificity cancer diagnosis.

[0038] The technical features of the above-described embodiments can be combined arbitrarily. For the sake of brevity of description, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, it should be considered as falling within the scope described in this specification.

[0039] The above-described embodiments merely represent several implementation manners of the present invention. The description is relatively specific and detailed, but it should not be construed as a limitation on the scope of the invention patent. It should be noted that for those of ordinary skill in the art, without departing from the concept of the present invention, several modifications and improvements can still be made, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the present invention patent shall be subject to the appended claims.

Claims

1. A method for targeted direct sequencing of sequences and epigenetic modifications of full-length RNA molecules based on nanopores, characterized in that: The 5' and 3' ends of the RNA molecule to be tested are extended by connecting an extension adapter, and the extended RNA molecule is subjected to nanopore sequencing.

2. The method for targeted direct sequencing of the sequence and epigenetic modification of full-length RNA molecules based on nanopores according to claim 1, characterized in that: The extension adapter consists of three parts: a DNA probe, a 5' extension RNA and a 3' extension RNA, wherein the 3' extension RNA comprises a poly-A tail for sequencing adapter ligation.

3. The method for targeted direct sequencing of the sequence and epigenetic modification of full-length RNA molecules based on nanopores according to claim 1, characterized in that: The method is applicable to a variety of nanopore sequencing platforms, including but not limited to the Oxford Nanopore Sequencing Platform and the Qitan Technology Nanopore Sequencing Platform.

4. An application of a method for targeted direct sequencing of sequences and epigenetic modifications of full-length RNA molecules based on nanopores as described in any one of claims 1 to 3, characterized in that: The method is applied to direct sequencing of full-length RNA.

5. The use according to claim 4, characterized in that The method is also applied to biological mechanism research or clinical research.

6. The use according to claim 5, characterized in that The method is applied to constructing a cancer diagnosis model.

Citation Information

Patent Citations

  • Nanopore based dislocation sequencing method for direct sequencing of non-natural nucleic acid

    CN109295187A